Analysis reveals GLO1's prognostic value in endometrial cancer, indicating its potential in immunotherapy across tumors.
This comprehensive pan-cancer study reveals the prognostic value and potential predictive role of GLO1 in immunotherapy across multiple tumor types. This study primarily utilized bioinformatic datasets; experimental validation was performed for endometrial cancer but warrants expansion to other cancer types in future work.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: